pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: Safety Study of HSV2 DNA Vaccine to Treat Patients With Recurrent Genital Herpes Caused by HSV-2
Status: COMPLETED
Conditions: HSV-2
Interventions: BIOLOGICAL: pPJV7630 administered by PMED
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Instrument Assisted Soft Tissue Mobilization Versus Dynamic Oscillatory Stretch Technique in Females Wearing High Heels
Status: RECRUITING
Conditions: Behavior, Social
Interventions: OTHER: Instrument Assisted Soft Tissue Mobilization|OTHER: Dynamic oscillatory stretch technique
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Nutritive Sucking Patterns in Premature Infants
Status: WITHDRAWN
Conditions: Premature|Light-For-Dates Without Mention of Fetal Malnutrition, Unspecified|Feeding Patterns
Interventions: DIAGNOSTIC_TEST: Reporting of sucking patterns captured by Instrumented Bottle|DIAGNOSTIC_TEST: Control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Removal of Ligand-bound Iron During Intravenous (IV) Iron Administration in Hemodialysis (HD)
Status: COMPLETED
Conditions: Hemodialysis Patients
Interventions: DEVICE: large pore (FX80) compared to small pore dialyzer (F8HPS)|OTHER: Dialysate bicarbonate of 33 mEq/L compared to 40 mEq/L|OTHER: Dialysate calcium of 3 mEq/L compared to 2.5 mEq/L
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose:
Clinical trial: HER2-Peptide Vaccination of Patients With Solid Tumors
Status: COMPLETED
Conditions: Gastric Cancer|Breast Cancer
Interventions: DRUG: Cyclophosphamide|DRUG: Sargramostim|DRUG: HER2-Peptid-Vakzine|DRUG: Imiquimod
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Preoperative IMRT With Concurrent Apatinib for Localised Extremity or Trunk Sarcoma
Status: RECRUITING
Conditions: Sarcoma,Soft Tissue|Extremity|Trunk|Intensity-modulated Radiotherapy|Targetd Therapy|Major Wound Complications
Interventions: DRUG: Apatinib Mesylate
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study Evaluating the Safety and the Efficacy of Human T Lymphoid Progenitor (HTLP) Injection to Accelerate Immune Reconstitution After Umbilical Cord Blood (UCB) Transplantation in Adult Patients with Hematologic Malignancies (HTLP-ONCO)
Status: RECRUITING
Conditions: Hematologic Malignancy
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Glucomannan Effects on Children With Non-alcoholic Fatty Liver Disease
Status: COMPLETED
Conditions: Metabolic Syndrome|Non Alcoholic Fatty Liver Disease|Insulin Resistance
Interventions: DIETARY_SUPPLEMENT: glucomannan|BEHAVIORAL: lifestyle intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Open-Label Drug Interaction Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) 100mg On The Pharmacokinetics Of Tamoxifen When Coadministered To Healthy Post-Menopausal Female Subjects
Status: COMPLETED
Conditions: Pharmacokinetics
Interventions: DRUG: Tamoxifen|DRUG: Tamoxifen and Desvenlafaxine Succinate Sustained Release
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Fasting Study of Modafinil Tablets 200 mg and Provigil® Tablets 200 mg
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: Modafinil Tablets 200 mg|DRUG: Provigil® Tablets 200 mg
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: OTHER
Clinical trial: A Study to Evaluate the Comparative Efficacy of CNTO 1959 (Guselkumab) and Secukinumab for the Treatment of Moderate to Severe Plaque-type Psoriasis
Status: COMPLETED
Conditions: Psoriasis
Interventions: DRUG: Guselkumab|DRUG: Placebo|DRUG: Secukinumab
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Nutritional Intervention to Decrease Breast Density Among Female BRCA (BReast CAncer Susceptibility Gene) Carriers
Status: COMPLETED
Conditions: BRCA1 Gene Mutation|BRCA2 Gene Mutation
Interventions: DIETARY_SUPPLEMENT: DIM-Avail 100mg
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: A Randomized, Open-label, Single Dose, Parallel Study to Evaluate the Pharmacokinetics Dose Proportionality of GLA5PR GLARS-NF1 Tablet in Healthy Male Volunteers
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: Pregabalin 150mg|DRUG: Pregabalin 300mg
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Efficacy and Safety of a Pentavalent Rotavirus Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Niger
Status: COMPLETED
Conditions: Severe Rotavirus Gastroenteritis
Interventions: BIOLOGICAL: Rotavirus vaccine (BRV-PV)|BIOLOGICAL: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Chronic Pain Management In Primary Care Using Behavioral Health Consultants
Status: RECRUITING
Conditions: Chronic Pain
Interventions: BEHAVIORAL: Brief Cognitive Behavioral Therapy for Chronic Pain (BCBT-CP)|OTHER: BCBT-CP Booster
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain
Status: COMPLETED
Conditions: Neuralgia|Peripheral Neuropathic Pain
Interventions: DRUG: Bupivacaine|DRUG: Depo-Medrol Injectable Product|OTHER: Saline (Sodium Chloride) solution|DRUG: Lidocaine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: DIAGNOSTIC
Clinical trial: Treatment of the Recessive Nonbullous Congenital Ichthyosis by the Epigallocatechine Cutaneous
Status: UNKNOWN
Conditions: Lamellar Ichthyosis
Interventions: DRUG: apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side|DRUG: apply VEREGEN ® 10 % on a randomized area and the moisturizing cream of the other side
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: CALM- 2 - Controlling and Lowering Blood Pressure With the MobiusHD™
Status: ACTIVE_NOT_RECRUITING
Conditions: Hypertension|Resistant Hypertension
Interventions: DEVICE: MobiusHD|OTHER: Sham Implantation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Esmolol Versus Lidocaine on the Quality of Postoperative Recovery in Patients Undergoing Functional Endoscopic Sinus Surgery
Status: ACTIVE_NOT_RECRUITING
Conditions: Chronic Rhinosinusitis|Enhanced Recovery After Surgery
Interventions: DRUG: Esmolol Injection|DRUG: Lidocaine IV
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Study of ADCT-502 in Patients With Advanced Solid Tumors Withhuman Epidermal Growth Factor Receptor-2 (HER2) Expression
Status: TERMINATED
Conditions: Breast Cancer|Non Small Cell Lung Cancer|GastroEsophageal Cancer|Bladder Cancer
Interventions: DRUG: ADCT-502
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Trial of Dasatinib (Sprycel®) in Subjects With Hormone-refractory Prostate Cancer
Status: COMPLETED
Conditions: Hormone-refractory Prostate Cancer|Adenocarcinoma of the Prostate|Hormone-resistant Prostate Cancer|Prostate Cancer|Recurrent Prostate Cancer
Interventions: DRUG: Dasatinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Pilot Study of Cognitive Behavior Therapy With Role-plays in Virtual Reality for Children With Behavior Problems
Status: NOT_YET_RECRUITING
Conditions: Child Behavior Problem|Disruptive Behavior|Oppositional Defiant Disorder|Conduct Problems|Aggression|Anger
Interventions: BEHAVIORAL: YourSkills: Cognitive behavioral therapy for children/youth with role-plays in virtual reality
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator DevicE
Status: COMPLETED
Conditions: Peripheral Arterial Disease
Interventions: DEVICE: Serranator™ Alto PTA Serration Balloon Catheter
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effects of Aromatherapy on Patient Satisfaction With Surgical Abortion at Less Than 10 Weeks Gestation
Status: UNKNOWN
Conditions: Surgical Abortion|Patient Satisfaction|Anesthesia|Pain
Interventions: OTHER: Placebo oil|OTHER: Lavender oil.
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: OTHER
Clinical trial: Percutaneous Electrolysis and Vacuum Myofascial Therapy deviceTrial.
Status: COMPLETED
Conditions: Epicondylitis
Interventions: DEVICE: Vacuum Myofascial Therapy device|OTHER: physical therapy program|PROCEDURE: Therapeutic Percutaneous Electrolysis|PROCEDURE: ultrasound pulsatil therapy (US) and massage
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Enhanced Collaborative Depression Treatment in Primary Care: The RESPECT-D-E Trial
Status: COMPLETED
Conditions: Depressive Disorder, Major|Depressive Disorder, Minor|Dysthymic Disorder
Interventions: OTHER: RESPECT-D|OTHER: RESPECT-D-E (Enhanced)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: The Influence of Fasting on Selected Hemodynamic Parameters Measured in a Non-invasive Way
Status: COMPLETED
Conditions: Perioperative Complication|Hemodynamic Instability
Interventions: DIETARY_SUPPLEMENT: Nutricia Pre-op, 400 milliliters, per os
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Microparticles in Stored RBC as Potential Mediators of Transfusion Complications
Status: COMPLETED
Conditions: Coronary Artery Bypass
Interventions: BIOLOGICAL: Washed RBC|BIOLOGICAL: Unwashed RBC
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Oral Glibenclamide in Preterm Infants With Hyperglycaemia (GALOP)
Status: RECRUITING
Conditions: Transient; Hypoglycemia, Neonatal|Preterm|Glibenclamide Adverse Reaction
Interventions: DRUG: Glibenclamide|BIOLOGICAL: Pharmacokinetics study|BIOLOGICAL: C-peptide proinsulin ratio|BIOLOGICAL: Blood glucose on fluorinated tube|BIOLOGICAL: Routine biological monitoring|BIOLOGICAL: glycose holter monitor
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Protection of Thyroid Function in IMRT for Nasopharyngeal Carcinoma
Status: RECRUITING
Conditions: Nasopharyngeal Carcinoma|Nasopharyngeal Cancer|Hypothyroidism
Interventions: RADIATION: Modified neck target volume delineation
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The PK/PD Study of A Single Subcutaneous Injection of SHR-1222 in Healthy Subjects
Status: COMPLETED
Conditions: Osteoporosis
Interventions: DRUG: SHR-1222|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety Study Involving Oxaliplatin With Docetaxel for Recurrent Ovarian,Primary Peritoneal, and Fallopian Tube Cancer
Status: COMPLETED
Conditions: Ovarian Cancer|Peritoneal Cancer|Fallopian Tube Cancer
Interventions: DRUG: intravenous docetaxel with intraperitoneal oxaliplatin|DRUG: intravenous oxaliplatin with intraperitoneal docetaxel
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies
Status: RECRUITING
Conditions: Liver Cancer
Interventions: DEVICE: TriNav|DEVICE: Traditional Delivery|DRUG: Doxorubicin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: REGistry of Long-term AnTithrombotic TherApy-1
Status: RECRUITING
Conditions: Coronary Artery Disease (CAD) (E.G., Angina, Myocardial Infarction, and Atherosclerotic Heart Disease (ASHD))|Peripheral Artery Disease
Interventions: DRUG: Antiplatelet Drug
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: A Pivotal Study of HQP1351 in Patients of Chronic Myeloid Leukemia in Accelerated Phase With T315I Mutation
Status: ACTIVE_NOT_RECRUITING
Conditions: Chronic Myeloid Leukemia - Accelerated Phase
Interventions: DRUG: HQP1351
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of Dry Needling on Gluteus Medius Contraction in Greater Trochanteric Pain Syndrome: a Pilot RCT Protocol
Status: NOT_YET_RECRUITING
Conditions: Greater Trocantheric Pain Syndrome
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy of Coffee Versus Peppermint Oil Intake in Promoting GIT Motility After Cesarean Section
Status: COMPLETED
Conditions: Gastrointestinal Motility and Defecation Conditions
Interventions: OTHER: Coffee effect on early gastric motility|OTHER: Efficacy pepper mint oil on motility
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: PREhabilitation in Patients Awaiting Acute Inpatient Cardiac SurgEry
Status: RECRUITING
Conditions: Cardiac Disease|Aortic Valve Disease|Coronary Artery Disease|Endocarditis|Valve Heart Disease
Interventions: OTHER: Prehabilitation
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Study of Ixekizumab (LY2439821) in Children 6 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis
Status: COMPLETED
Conditions: Plaque Psoriasis
Interventions: DRUG: Ixekizumab|DRUG: Placebo|DRUG: Etanercept
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Cervical Neuromodulation and Nociceptive Processing
Status: COMPLETED
Conditions: Nociceptive Pain
Interventions: DEVICE: Starstim (Neuroelectrics)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in Epilepsy
Status: COMPLETED
Conditions: Epilepsy, Partial
Interventions: DRUG: Levetiracetam
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: CSF Protein Markers as Prognostic Indicators of the Response to CSF Shunt in Normotensive Hydrocephalus
Status: RECRUITING
Conditions: Cerebrospinal Fluid Levels of Amyloid Beta 1-42, H-tau and Phospho-tau Proteins|Cognitive Impairment and Its Evolution After Hydrocephalus Treatment|Motor Impairment and Its Evolution After Hydrocephalus Treatment|Ventricular Size and Its Evolution After Implantation of a Ventriculoperitoneal Shunt
Interventions: DIAGNOSTIC_TEST: Lumbar CSF protein marker determination
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Renal Effects of Treatment With Empagliflozin Alone or in Combination With Semaglutide in Patients With Type 2 Diabetes and Albuminuria
Status: UNKNOWN
Conditions: Type 2 Diabetes With Renal Manifestations
Interventions: DRUG: Semaglutide, 1.34 mg/mL|OTHER: Placebo, 1,34 mg/mL|DRUG: Empagliflozin 25 MG
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Efficacy of Anti-CD20 Ab Associated With Anti-CD38 in the Childhood Multidrug Dependent and Resistant Nephrotic Syndrome
Status: RECRUITING
Conditions: Nephrotic Syndrome
Interventions: DRUG: Rituximab Biosimilar ABP 798|DRUG: Daratumumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Oral Versus Intravenous Rehydration for Prevention of Dehydration in Premature Babies, During the First Days of Life.
Status: COMPLETED
Conditions: Low Birth Weight Infant|Enteral Nutrition
Interventions: PROCEDURE: Oral rehydration therapy|PROCEDURE: classical hydration via intravenous infusion
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Patient-Centered Decision Support to Improve Diabetes Management in Pre-Teens and Adolescents With Type 1 Diabetes
Status: COMPLETED
Conditions: Diabetes Mellitus
Interventions: OTHER: Arm 1
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Circulating microRNAs as Biomarkers of RESPIratory Dysfunction in Patients With Refractory epilePSY
Status: COMPLETED
Conditions: Drug Resistant Epilepsy
Interventions: GENETIC: blood sample
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Early Prophylaxis Immunologic Challenge (EPIC) Study
Status: TERMINATED
Conditions: Hemophilia A
Interventions: BIOLOGICAL: Recombinant antihemophilic factor, plasma/albumin-free method (rAHF-PFM)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Esophageal Metaplasia Using a Novel Antibody: Reversibility by Proton Pump Inhibitor
Status: TERMINATED
Conditions: Esophageal Metaplasia
Interventions: DRUG: Ranitidine & Pantoprazole
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: Identification of Microcirculation and Inflammation After Posterior Stabilization of the Spine
Status: COMPLETED
Conditions: Vertebral Fracture
Interventions: PROCEDURE: Mantis|PROCEDURE: XIA
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: The Model and Effect Assessment of Training General Practitioner for Dementia Early Recognition
Status: COMPLETED
Conditions: Dementia
Interventions: OTHER: lessons,long-term supervision and message|OTHER: lessons,short-term supervision and message
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Offset Mechanisms in Evaluation of Lumbar Medial Branch Blocks
Status: RECRUITING
Conditions: Pain, Chronic|Facet Joint Pain|Pain, Procedural|Analgesia
Interventions: BEHAVIORAL: Cutaneous Probe|BEHAVIORAL: Quantitative Sensory Testing|BEHAVIORAL: Computer Tasks
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Microcurrent for Fibromyalgia
Status: RECRUITING
Conditions: Fibromyalgia
Interventions: DEVICE: Microcurrent Transcutaneous Electrical Nerve Stimulator (TENS) for pain relief|DEVICE: PLACEBO Microcurrent Transcutaneous Electrical Nerve Stimulator (TENS) for pain relief
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Virtual Reality Place in the Management of Body Dysmorphia Disorders in Anorexia Nervosa
Status: NOT_YET_RECRUITING
Conditions: Anorexia Nervosa|Dysmorphophobia
Interventions: OTHER: Experimental group 1 : Virtual Reality|OTHER: Experimental group 2 : Virtual Reality + Multi Sensorial Remediation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Cyclophosphamide and Pulse Dexamethasone With Rapamycin or Hydroxychloroquine
Status: COMPLETED
Conditions: Myeloma
Interventions: DRUG: Hydroxychloroquine|DRUG: Rapamycin
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: |Primary Purpose: TREATMENT
Clinical trial: Efficacy of Deep Cervical Flexor Muscles Training on Neck Pain, Functional Disability and Muscle Endurance in School Teachers
Status: COMPLETED
Conditions: Neck Pain
Interventions: BEHAVIORAL: DCF muscles training using pressure biofeedback in addition to conventional exercises|BEHAVIORAL: conventional exercises
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Pilot Study to Assess the Safety and Pharmacokinetics of 70-150μm Drug Eluting Beads Loaded With Irinotecan (DEBIRI).
Status: COMPLETED
Conditions: Colorectal Cancer Metastatic
Interventions: DEVICE: DEBIRI
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Allogeneic Gamma-delta T Cells Combined With Targeted Therapy and Immunotherapy in a Phase 1 Clinical Trial of Hepatocellular Carcinoma Resistant to PD-1 Monoclonal Antibody
Status: NOT_YET_RECRUITING
Conditions: Hepatocellular Carcinoma
Interventions: BIOLOGICAL: γδ T cells|DRUG: PD-1 monoclonal antibody|DRUG: targeted drugs
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The LIFE Study - Lifestyle Interventions and Independence for Elders
Status: COMPLETED
Conditions: Sedentary Lifestyle|Risk of Disability|Aging
Interventions: BEHAVIORAL: Physical Activity|BEHAVIORAL: Successful Aging
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Using Digitalized Incentive Spirometers to Assist Postoperative Rehabilitation of Abdominal Surgery Patients
Status: NOT_YET_RECRUITING
Conditions: Bariatric Surgery Candidate|Sleep Apnea, Obstructive
Interventions: DEVICE: digitalized incentive spirometry|DEVICE: traditional incentive spirometry
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female Patients
Status: COMPLETED
Conditions: Irritable Bowel Syndrome
Interventions: DRUG: YM060|DRUG: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Status: ACTIVE_NOT_RECRUITING
Conditions: Glioblastoma
Interventions: BIOLOGICAL: Personalized neoantigen DNA vaccine supplied by Geneos Therapeutics|DEVICE: CELLECTRA®2000 EP Device supplied by Geneos Therapeutics|DRUG: Plasmid encoded IL-12
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study Evaluating the Safety, Pharmacokinetics and Efficacy of Ipatasertib Administered in Combination With Rucaparib in Participants With Advanced Breast, Ovarian Cancer, and Prostate Cancer.
Status: COMPLETED
Conditions: Breast Cancer|Prostate Cancer|Ovarian Cancer
Interventions: DRUG: Ipatasertib|DRUG: Rucaparib
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Axillary Drainage Following Lymph Node Dissection in Women With Stage I or Stage II Breast Cancer
Status: UNKNOWN
Conditions: Breast Cancer|Lymphedema|Perioperative/Postoperative Complications
Interventions: PROCEDURE: management of therapy complications
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Manifestations of Ocular Irritation Following Pterygium Excision With Sutures Fixed Conjunctival Autograft
Status: COMPLETED
Conditions: Pterygium
Interventions: PROCEDURE: pterygium excision with sutures fixed conjunctival auto-graft
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Problem of Colorectal Anastomosis Safety
Status: COMPLETED
Conditions: Colorectal Cancer|Colorectal Carcinoma|Colorectal Neoplasms|Colorectal Adenocarcinoma
Interventions: PROCEDURE: Indocyanine green fluorescent angiography intraluminally and intraperitoneally
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Study of Tranexamic Acid During Air and Ground Medical Prehospital Transport Trial (STAAMP Trial)
Status: COMPLETED
Conditions: Traumatic Hemorrhage
Interventions: DRUG: Tranexamic Acid|OTHER: Saline control
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Ultrasound Therapy and Manual Therapy in Digital Ischemic Ulcers
Status: COMPLETED
Conditions: Systemic Sclerosis
Interventions: OTHER: combination ultrasound therapy and manual therapy|OTHER: manual therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Natural Orifice Translumenal Endoscopic Surgery (NOTES) Transvaginal Cholecystectomy
Status: COMPLETED
Conditions: Cholelithiasis|Biliary Dyskinesia
Interventions: PROCEDURE: NOTES Transvaginal Cholecystectomy
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Prophylaxis With Apixaban in Transplant Eligible Patients With Multiple Myeloma Receiving Induction Therapy With IMiDs
Status: TERMINATED
Conditions: Venous Thromboembolism
Interventions: DRUG: Apixaban 2.5 MG
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effectiveness of Tai Chi to Improve Cognitive Function in Older Adults With Mild Cognitive Impairment
Status: COMPLETED
Conditions: Mild Cognitive Impairment
Interventions: OTHER: Tai Chi training|OTHER: Conventional exercise
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: IV vs. IA tPA (Activase) in Acute Ischemic Stroke With CTA Evidence of Major Vessel Occlusion
Status: COMPLETED
Conditions: Ischemic Stroke
Interventions: DRUG: IV tpa (Alteplase) vs IA tpa (Alteplase)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Tolerability of TG1050: A Dose-finding Study
Status: COMPLETED
Conditions: Chronic Hepatitis B
Interventions: BIOLOGICAL: TG1050|BIOLOGICAL: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Long-term Characterization of Patients With Severe/Critical Infection by COVID-19 Virus
Status: COMPLETED
Conditions: Covid19
Interventions: RADIATION: chest radiography|RADIATION: thoracic computed tomography scan|DIAGNOSTIC_TEST: spirometry|DIAGNOSTIC_TEST: Diffusing capacity of carbon monoxide|DIAGNOSTIC_TEST: 6 minute walk test|DIAGNOSTIC_TEST: saint george respiratory questionnaire
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Evaluate the Safety and Effectiveness of the enVista® One-Piece Hydrophobic Acrylic Trifocal Intraocular Lens
Status: COMPLETED
Conditions: Cataract
Interventions: DEVICE: enVista MX60E|DEVICE: enVista MX60EF
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults
Status: COMPLETED
Conditions: Influenza
Interventions: BIOLOGICAL: PanBlok|BIOLOGICAL: rHA adjuvant
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Integrated Pulmonary Index for Nurse-administered Procedural Sedation
Status: COMPLETED
Conditions: Conscious Sedation|Nursing|Anaesthesia
Interventions: DEVICE: Integrated Pulmonary Index|DEVICE: Standard capnography monitoring
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial
Status: RECRUITING
Conditions: Advanced Esophageal Adenocarcinoma|Advanced Gastric Adenocarcinoma|Advanced Gastroesophageal Junction Adenocarcinoma|Clinical Stage II Esophageal Adenocarcinoma AJCC v8|Clinical Stage III Esophageal Adenocarcinoma AJCC v8|Clinical Stage III Gastric Cancer AJCC v8|Clinical Stage III Gastroesophageal Junction Adenocarcinoma AJCC v8|Clinical Stage IV Esophageal Adenocarcinoma AJCC v8|Clinical Stage IV Gastric Cancer AJCC v8|Clinical Stage IV Gastroesophageal Junction Adenocarcinoma AJCC v8|Metastatic Esophageal Adenocarcinoma|Metastatic Gastric Adenocarcinoma|Metastatic Gastroesophageal Junction Adenocarcinoma|Unresectable Esophageal Adenocarcinoma|Unresectable Gastric Adenocarcinoma|Unresectable Gastroesophageal Junction Adenocarcinoma
Interventions: PROCEDURE: Biospecimen Collection|PROCEDURE: Computed Tomography|PROCEDURE: Magnetic Resonance Imaging|BIOLOGICAL: Nivolumab|DRUG: Paclitaxel|OTHER: Questionnaire Administration|BIOLOGICAL: Ramucirumab
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study to Investigate the Efficacy of Symbicort® SMART.
Status: COMPLETED
Conditions: Asthma
Interventions: DRUG: Symbicort Turbuhaler|DRUG: Terbutaline Turbuhaler
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study of LY2140023 in Patients With Schizophrenia
Status: TERMINATED
Conditions: Schizophrenia
Interventions: DRUG: LY2140023|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Surgical Result of Pterygium Extended Removal Followed by Fibrin Glue Assisted Amniotic Membrane Transplantation
Status: UNKNOWN
Conditions: Pterygium|Recurrence
Interventions: PROCEDURE: P.E.R.F.A.M.T
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Neuropathic Pain Study With Botulinum Toxin A in Spinal Cord Injury Patients
Status: COMPLETED
Conditions: Spinal Cord Injury|Neuropathic Pain
Interventions: DRUG: Botulinum toxin type A|DRUG: normal saline
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Asymptomatic Carotid Stenosis and Mobility Function With Exercise Intervention
Status: RECRUITING
Conditions: Asymptomatic Carotid Stenosis (50-69%)|Mobility Impairment
Interventions: OTHER: Exercise Intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
Status: UNKNOWN
Conditions: Lung Cancer
Interventions: DRUG: cisplatin|DRUG: gemcitabine hydrochloride|DRUG: vinorelbine tartrate
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: |Masking: |Primary Purpose: TREATMENT
Clinical trial: A Deep Longitudinal Analysis of Next Generation Influenza Vaccines in Older Adults
Status: RECRUITING
Conditions: Aging|Influenza Vaccine|Dendritic Cell|Vaccine Response
Interventions: BIOLOGICAL: Flu Vaccine (Year 1)|BIOLOGICAL: Flu Vaccine (Year 2)|BIOLOGICAL: Flu Vaccine (Year 3)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Acute Effects of Strengthening Lower Limbs Operated by Total Knee Arthroplasty
Status: COMPLETED
Conditions: Total Knee Arthroplasty
Interventions: OTHER: Strengthening|OTHER: Conventional protocol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: NanoCross BTK, a Prospective, Non-randomized, Multicenter, Controlled Trial Evaluating the Performance of the NanoCrossTM .014 Balloon Catheter in Infrapopliteal Lesions
Status: COMPLETED
Conditions: Peripheral Arterial Disease
Interventions: DEVICE: NanoCross .014 balloon catheter
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Response of Cardiac Resynchronization Therapy Optimization With Ventricle to Ventricle Timing in Heart Failure Patients
Status: COMPLETED
Conditions: Heart Failure
Interventions: DEVICE: Simultaneous VV Pacing|DEVICE: Sequential VV Pacing
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Dronabinol in Trichotillomania and Other Body Focused Repetitive Behaviors
Status: COMPLETED
Conditions: Trichotillomania|Skin-Picking
Interventions: DRUG: Dronabinol|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Indocyanine Green Fluorescence in Evaluation of Pancreatic Remnant Perfusion.
Status: RECRUITING
Conditions: Pancreatic Fistula
Interventions: DIAGNOSTIC_TEST: Perioperative assessment of the perfusion of post-resection pancreatic remnant using indocyanine green-VerDye
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Anti-reflux Mucosal Ablation Therapy Randomized Sham Control Trial for Gastroesophageal Reflux Disease
Status: NOT_YET_RECRUITING
Conditions: Gastroesophageal Reflux Disease
Interventions: PROCEDURE: Antireflux mucosal ablation|PROCEDURE: Sham procedure
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: TREATMENT
Clinical trial: On-demand PPI Therapy is Effective on Controlling Symptoms in Patients With Barrett's Esophagus.
Status: COMPLETED
Conditions: Barrett Esophagus|Proton Pump Inhibitor|Symptom|Reflux
Interventions: DRUG: Esomeprazole 40mg|DRUG: Esomeprazole
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Evaluation of Macular Structural and Functional Function Following Extensive Retinal Laser Therapy in Patients With Proliferative Diabetic Retinopathy
Status: COMPLETED
Conditions: Diabetes Mellitus, Type 2
Interventions: PROCEDURE: Panretinal Photocoagulation (PRP)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Endoscopic Band Ligation (EBL) Versus Propranolol for Primary Prophylaxis of Variceal Bleeding
Status: UNKNOWN
Conditions: Variceal Bleeding|Cirrhosis
Interventions: PROCEDURE: Endoscopic band ligation|DRUG: Propranolol|PROCEDURE: EBL+Propranolol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: SLlt Stent II Lacrimal Stent for the Treatment of Nasolacrimal Duct Obstruction
Status: SUSPENDED
Conditions: Epiphora|Dacryocystorhinostomy
Interventions: DEVICE: Slit Stent II|DEVICE: BIKA for DCR
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: The Role of Central Venous Oxygen Saturation (ScvO2) as an Indicator of Blood Transfusion in the Critically Ill
Status: UNKNOWN
Conditions: Blood Transfusion; Hemoglobinemia|Hypoxia|Anemia
Interventions: BIOLOGICAL: Blood transfusion
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Neuromuscular Electrical Stimulation (NMES) in Patients With Intermittent Claudication
Status: COMPLETED
Conditions: Intermittent Claudication|Peripheral Vascular Disease
Interventions: DEVICE: Neuromuscular Electrical Stimulation
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Narrow Implants Vs Standard Implants With Simultaneous GBR
Status: RECRUITING
Conditions: Narrow Implant|Dental Implant|Bone Regeneration
Interventions: PROCEDURE: Test group|PROCEDURE: Control group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Written Exposure Therapy and App-Delivered Mindfulness Meditation for PTSD in China: A Pilot Study
Status: RECRUITING
Conditions: PTSD|Insomnia, Secondary
Interventions: BEHAVIORAL: written exposure therapy|BEHAVIORAL: Written Exposure Therapy plus Mindfulness-Based App (WET + MBA)|BEHAVIORAL: Minimal Contact Control (MCC)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Intranasal Fentanyl as an Adjunct to Lidocaine Infiltration in Adults Undergoing Abscess Incision and Drainage
Status: COMPLETED
Conditions: Abscess
Interventions: DRUG: Intranasal fentanyl|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Microbiome in Pulmonary Tuberculosis, Non-tuberculous Mycobacterial Pulmonary Diseases, Lung Cancer and Hemoptysis
Status: COMPLETED
Conditions: Tuberculosis, Pulmonary|Non-Tuberculous Mycobacterial Pneumonia|Lung Cancer|Hemoptysis
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: CINC424A2X01B Rollover Protocol
Status: RECRUITING
Conditions: Primary Myelofibrosis|Polycythemia Vera|Graft Versus Host Disease|Acute Myeloid Leukemia|Thalassemia
Interventions: DRUG: ruxolitinib|DRUG: panobinostat
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Impulsivity and Thought Process Disorder in Patients With Active Suicidal Ideation and Depression
Status: WITHDRAWN
Conditions: Impulsivity|Active Suicidal Ideation|Depression
Interventions: OTHER: placebo|DRUG: Riperidone
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Effects of Active Prewarming in Perioperative Hypothermia in Adults
Status: COMPLETED
Conditions: Hypothermia; Anesthesia|Hypothermia Due to Anesthetic|Hypothermia Following Anesthesia|Hypothermia Following Anesthesia, Sequela
Interventions: DEVICE: Forced air warming devices
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Effect of Diacerein vs Celecoxib on Symptoms and Structural Changes in Symptomatic Knee Osteoarthritis
Status: COMPLETED
Conditions: Osteoarthritis|Osteoarthritis, Knee
Interventions: DRUG: Diacerein|DRUG: Celecoxib|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Lap-assisted vs. US-Guided Visualization of TAP Blocks
Status: COMPLETED
Conditions: Pain, Postoperative
Interventions: PROCEDURE: Laparoscopic|PROCEDURE: Ultrasound
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Digestibility of Selected Resistant Starches in Humans
Status: COMPLETED
Conditions: Malabsorption; Carbohydrate|Ileostomy - Stoma
Interventions: OTHER: Starch-free breakfast|OTHER: Hi-Maize 260|OTHER: Hylon VII|OTHER: Amioca
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose:
Clinical trial: Cost-efficacy of Atraumatic Restorations (ART) Using Different Encapsulated Glass Ionomer Cement
Status: COMPLETED
Conditions: Dental Caries
Interventions: PROCEDURE: ART with Equia|PROCEDURE: ART with Riva Self Cure
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Repeated Dosing Study to Assess Safety and Tolerability in CKD-3 Patients on Stable ACE-I Treatment
Status: COMPLETED
Conditions: Chronic Kidney Disease
Interventions: DRUG: SAR407899A
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer
Status: COMPLETED
Conditions: Breast Cancer|Stage IV Breast Cancer
Interventions: PROCEDURE: palliative surgery|PROCEDURE: therapeutic conventional surgery|RADIATION: palliative radiation therapy|RADIATION: radiation therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of Nitrous Oxide in Treating Neuropathic Pain: A Study in Chronic Low Back Pain Patients
Status: COMPLETED
Conditions: Low Back Pain|Radiating Pain
Interventions: OTHER: Entonox|OTHER: Oxygen
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Carfilzomib + Elotuzumab + Dexamethasone for Relapsed Multiple Myeloma After 1-3 Prior Treatment Lines
Status: COMPLETED
Conditions: Multiple Myeloma in Relapse
Interventions: DRUG: Carfilzomib for Inj 60 milligram (MG)|DRUG: Elotuzumab 400 MG|DRUG: Dexamethasone
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Transcranial Alternating Current Stimulation (tACS) in Patients With Ataxia
Status: COMPLETED
Conditions: Ataxia|Spinocerebellar Ataxias|Multiple System Atrophy|Ataxia With Oculomotor Apraxia|CANVAS
Interventions: DEVICE: Transcranial stimulation over the cerebellar hemispheres
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: The Effect of Acupressure in Non-breastfeeding Mothers After Preterm Cesarean Delivery
Status: UNKNOWN
Conditions: Acupressure|Breastfeeding
Interventions: OTHER: acupressure
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Effect of Pentoxifylline Versus Probiotic on Preterm Neonates With Necrotizing Enterocolitis
Status: COMPLETED
Conditions: Necrotizing Enterocolitis
Interventions: DRUG: Pentoxifylline|DRUG: Probiotic Formula
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Impact of Venlafaxine on Apnea Hypopnea Index in Obstructive Sleep Apnea
Status: COMPLETED
Conditions: Obstructive Sleep Apnea
Interventions: DRUG: Venlafaxine|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Quality of Life and Sjögren Syndrome
Status: COMPLETED
Conditions: Xerostomia|Hyposalivation|Quality of Life|Sjogren's Syndrome
Interventions: DRUG: Xeros|DRUG: Citric Acid based Mouthwash
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT